RHÖN-KLINIKUM AG

  • WKN: 704230
  • ISIN: DE0007042301
  • Land: Deutschland

Nachricht vom 09.07.2020 | 15:59

RHÖN-KLINIKUM Aktiengesellschaft: Management Board of RHÖN-KLINIKUM AG Welcomes New Partnership with Asklepios

DGAP-News: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Mergers & Acquisitions/Miscellaneous
09.07.2020 / 15:59
The issuer is solely responsible for the content of this announcement.

 

Corporate News
 

Bad Neustadt / Saale | 9th July 2020
 

Management Board of RHÖN-KLINIKUM AG Welcomes New Partnership with Asklepios

The Management Board of RHÖN-KLINIKUM AG welcomes the new partnership with Asklepios Kliniken GmbH & Co. KGaA. The voluntary public takeover offer to the shareholders of RHÖN-KLINIKUM AG has been completed. Asklepios and Eugen Münch now hold 92.58 % of RHÖN-KLINIKUM AG shares with voting rights. The takeover has therefore been successfully concluded.

RHÖN-KLINIKUM AG with its five sites providing maximum and intermediate medical care will continue to remain an independent enterprise - under the roof of the Asklepios Group. RHÖN and Asklepios will strategically complement each other on several levels and be strong together in the future. The hospital industry is facing huge challenges due to the increasing regulatory and demographic framework conditions. Acting together is essential in such a situation. Together with Asklepios we can make an even greater contribution to medical progress and providing forward-looking healthcare. As a beacon in medical care the university hospitals in Giessen and Marburg will play a key role in the strategic partnership with Asklepios.

Prof. Dr. Bernd Griewing, Medical Board Member of RHÖN-KLINIKUM AG, stated: "Together we wish to develop avantgarde concepts for healthcare and drive them forwards with a good portion of positive energy. RHÖN-KLINIKUM AG stands for excellent medical care with a direct link to universities and research institutes. Being under one roof enables us to make the best possible use of the corporate group economies of scale in each and every individual hospital. Savings which are made due to such economies of scale can remain with the Company where they will be used to create new jobs and investments in modern patient care."

Dr. Gunther Weiß, Operative Board Member of RHÖN-KLINIKUM AG, added: "Our two university hospitals in Giessen and Marburg are strong, traditional and solid university hospitals which belong to the best university hospitals in Germany from a medical and scientific as well as economic perspective. We can therefore be proud of what we have achieved since the federal state of Hesse resolved to privatise the hospitals. As a private hospital operator we have invested over Euro 680 million from our own funds in the two sites since the privatisation of the university hospitals in Giessen and Marburg."

RHÖN-KLINIKUM AG has consistently taken the opportunity to develop new areas of growth in the past few years. Entering the forward-looking telemedicine market, the RHÖN campus concept for offering healthcare across sectoral boundaries as well as consistently extending our corporate digitalisation have hitherto been key pillars of our corporate strategy. Together with Asklepios we wish to continue to drive the digitalisation of our hospitals forwards in a resolute manner and commit to the growth market of telemedicine as well as the use of artificial intelligence to help protect earnings in order to strengthen the partnership.

As one of the most innovative healthcare providers in Germany our campus concept has established a forward-looking healthcare model providing integrated and digitalised medical care which allows holistic patient care across the boundaries of out-patient and in-patient medical care due to all the people involved in the treatment of the patient being in a close digital network. Preventative services, out-patient and in-patient medical care, rehab care, promoting better health and offering telemedical services are the cornerstones of this innovative concept with the patient at its centre.


--------------------------------------------------

RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. Over 860,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where more than 18,000 employees work. RHÖN-KLINIKUM AG is currently exploiting the opportunities available to develop new areas of growth. Entering the forward-looking telemedicine market with Medgate Deutschland, the innovative RHÖN campus concept for offering avantgarde healthcare across sectoral boundaries in rural areas as well as consistently extending our gradual corporate digitalisation are key pillars of the corporate strategy.

More information under www.rhoen-klinikum-ag.com


More information on the takeover offer can be found on our website under the Investor Relations menu: https://www.rhoen-klinikum-ag.com/investor-relations.html

Follow us:

www.twitter.com/rhoenklinikumag

www.xing.com/companies/rhön-klinikumag

www.youtube.com/rhönklinikumag

Contact Persons:

RHÖN-KLINIKUM AG | Head of Corporate Communications and Marketing
Elke Pfeifer
Telephone: +49 9771 65-12110 | E-Mail: elke.pfeifer@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Head of Investor Relations und Treasury
Julian Schmitt
Telephone: +49 9771 65-12250 | E-Mail: julian.schmitt@rhoen-klinikum-ag.com

RHÖN-KLINIKUM AG | Schlossplatz 1 | 97616 Bad Neustadt / Saale, Germany



09.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC-Fokusbox

Anleihe der German Real Estate Capital S.A. stark überdurchschnittlich attraktiv

Die Anleihe der German Real Estate Capital S.A. weist aktuell eine Effektivverzinsung von ca. 14 % auf. Da es sich hier quasi um eine Immobilien-Anleihe handelt, ist das Anleiherisiko überschaubar. Insgesamt verfügt die German Real Estate-Gruppe über 6 Objekte, 24 Bestands- und 22 Handelsobjekte, womit eine Kombination aus stetigen Einnahmen und attraktiven Entwicklerrenditen erreicht wird. Wir stufen die Anleihe als stark überdurchschnittlich attraktiv ein.

News im Fokus

E.ON SE: E.ON trotz Covid-19-Effekten mit robustem Halbjahresergebnis

12. August 2020, 07:00

Aktueller Webcast

home24 SE

Webcast Q2 Results 2020

14. August 2020

Aktuelle Research-Studie

Nebelhornbahn-AG

Original-Research: Nebelhornbahn-AG (von GBC AG): Kaufen

11. August 2020